Drug Type Biosimilar, Monoclonal antibody |
Synonyms Adalimumab Biosimilar (Alvotech hf), 阿达木单抗生物类似药(Alvotech hf), AVTO2 |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | NDA/BLA | US | - | 12 Oct 2022 |